Algert Global LLC Xenon Pharmaceuticals Inc. Transaction History

Algert Global LLC

  • $5.98 Billion
  • Q3 2025

A detailed history of Algert Global LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Algert Global LLC holds 54,255 shares of XENE stock, worth $2.21 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
54,255
Previous 102,345 46.99%
Holding current value
$2.21 Million
Previous $3.2 Million 32.0%
% of portfolio
0.04%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$30.3 - $40.15 $1.46 Million - $1.93 Million
-48,090 Reduced 46.99%
54,255 $2.18 Million
Q2 2025

Aug 13, 2025
SELL
$28.23 - $38.37 $594,806 - $808,455
-21,070 Reduced 17.07%
102,345 $3.2 Million
Q1 2025

May 13, 2025
SELL
$33.55 - $40.74 $3.96 Million - $4.81 Million
-118,002 Reduced 48.88%
123,415 $4.14 Million
Q4 2024

Feb 14, 2025
BUY
$38.14 - $45.74 $830,384 - $995,851
21,772 Added 9.91%
241,417 $9.46 Million
Q3 2024

Nov 12, 2024
BUY
$36.12 - $43.96 $1.32 Million - $1.6 Million
36,440 Added 19.89%
219,645 $8.65 Million
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $29,362 - $35,437
-810 Reduced 0.44%
183,205 $7.14 Million
Q1 2024

May 14, 2024
SELL
$42.66 - $50.04 $1.42 Million - $1.67 Million
-33,305 Reduced 15.33%
184,015 $7.92 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $2.55 Million - $4.13 Million
88,833 Added 69.14%
217,320 $10 Million
Q3 2023

Nov 13, 2023
SELL
$34.16 - $39.73 $559,882 - $651,174
-16,390 Reduced 11.31%
128,487 $4.39 Million
Q2 2023

Aug 14, 2023
BUY
$34.84 - $43.54 $3.71 Million - $4.64 Million
106,470 Added 277.22%
144,877 $5.58 Million
Q1 2023

May 12, 2023
BUY
$33.46 - $40.35 $66,618 - $80,336
1,991 Added 5.47%
38,407 $1.38 Million
Q4 2022

Feb 13, 2023
SELL
$33.06 - $39.43 $291,919 - $348,166
-8,830 Reduced 19.52%
36,416 $1.44 Million
Q3 2022

Nov 15, 2022
BUY
$30.79 - $39.82 $580,145 - $750,288
18,842 Added 71.36%
45,246 $1.63 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $364,555 - $503,842
14,330 Added 118.68%
26,404 $803,000
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $302,936 - $400,011
12,074 New
12,074 $369,000

Others Institutions Holding XENE

# of Institutions
239
Shares Held
73.9M
Call Options Held
235K
Put Options Held
271K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.54B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email